Brief: LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
24/04/2023 22:06
April 24 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM
BID
PRICE DEFICIENCY
* LUMIRADX: GOT NOTIFICATION FROM NASDAQ THAT IT IS NOT IN
COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT IN LISTING RULE
FOR CONTINUED LISTING ON NASDAQ
Source text for Eikon: ID:nGNX31xypY
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing